For almost 60 years, measuring cholesterol levels in the blood has been the best way to identify individuals at high risk of ...

Cardiovascular disease remains the world's top killer, but early detection through better blood testing could dramatically ...

Firmly established as an icon to British youth, the Londoner discusses his upcoming fourth album, masculinity in the wake of ...

Two novel agents targeting angiopoietin-like protein 3 demonstrated safety and lipid-lowering capabilities in phase 2 trials, ...

Researchers in Sweden and the US suggest measuring levels of lipoproteins may be a more accurate risk predictor.

MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp(a) inhibitor from China's Jiangsu Hengrui Pharma for $200 million upfront. The deal gives MSD exclusive rights to ...

The licensing follows phase II results announced in November demonstrating that of patients on the highest dose of TQJ230 of 20 mg once-weekly, 98% saw Lp(a) levels drop below the recommended risk ...

as the Roches and released their eponymously titled first LP to ecstatic reviews. That album, “The Roches,” deserves its reputation. If you don’t know “Hammond Song,” well, your homework ...

Callaway has been busy lately. Within just the last few weeks, the company has launched a new Mini Driver, two new Triple ...

Statistically significant improvements observed across clinical endpoints; final cohort results expected in Q2 2025 ...

Labour Party, LP, Akoko-Edo Ward 1 Chairman in Edo State and a realtor, Okasime Olowojoba has been kidnapped on the ...